epiXchange conference 2018 - A community building event for epilepsy research
23 May 2018 - 24 May 2018
Belgium
epiXchange brings together the excellence of epilepsy research in Europe for a conference in Brussels on 23 May 2018. The main goal is to showcase major findings from seven large European epilepsy research projects, discuss the main bottlenecks and recommendations to move forward and to bring research results closer to clinical application.
www.epiXchange2018.eu. Stay tuned, #LiveStreaming available!
In connection to the scientific conference, the European Commission together with epiXchange partners organise a workshop on 24 May.
ORGANISERS:
Seven large EC-funded projects on epilepsy co-organise this conference to disseminate project results and discuss the future of epilepsy research in the EU and worldwide.
Four of the projects (DESIRE, EpimiRNA, EPISTOP and EpiTarget), still ongoing FP7 collaborative research projects, co-financing the event. Scientific contributions are provided by partners from EpiCare, an ongoing reference network project, as well as EpiPGX (FP7 collaborative research project) and Epixchange (FP7 MSCA ITN project), which are now finished.
These research projects aim to understand the various causes of epilepsy, enable complex diagnostics and suggest new ways of treatment. Therefore, the epiXchange conference centers following main themes:
GENETICS:
State of the art and beyond state of the art exploring and developing novel treatment strategies based on optogenetics, gene and stem cell therapies.
THERAPEUTICS:
Development of effective epileptogenic therapeutics face different kinds of bottlenecks e.g. regulatory hurdles.
BIOMARKERS:
In order to develop novel preventive strategies in at-risk patients the identification of new biomarkers in blood, peripheral organs, braun tissue, electrophysical data, behavioural data and imaging data.
BIOBANKS AND DATABASES:
Biobanks and databases facilitate preclinical research and could be integrated into clinical care. A collaborative approach will lay a foundation for the future of epilepsy research and other disease model biobanks.
CO-MORBIDITIES:
The burden of co-morbidities in epilepsy is high. Mechanisms underlying bidirectional relations between epilepsy and neurological co-morbidities still need to be explored.
REGISTRATION:
The deadline for registration is 24 April 2018. To register, please click here: http://www.epixchange2018.eu/registration
epiXchange is a dissemination activity of the FP7 funded projects DESIRE, EpimiRNA, EpiTarget and EPISTOP. DESIRE, EpimiRNA, EpiTarget and EPISTOP are Collaboration Projects funded by the European Union's 7th Framework Programme under respectively grant agreement n° 602531, n° 602130, n° 602102, n° 602391.
www.epiXchange2018.eu. Stay tuned, #LiveStreaming available!
In connection to the scientific conference, the European Commission together with epiXchange partners organise a workshop on 24 May.
ORGANISERS:
Seven large EC-funded projects on epilepsy co-organise this conference to disseminate project results and discuss the future of epilepsy research in the EU and worldwide.
Four of the projects (DESIRE, EpimiRNA, EPISTOP and EpiTarget), still ongoing FP7 collaborative research projects, co-financing the event. Scientific contributions are provided by partners from EpiCare, an ongoing reference network project, as well as EpiPGX (FP7 collaborative research project) and Epixchange (FP7 MSCA ITN project), which are now finished.
These research projects aim to understand the various causes of epilepsy, enable complex diagnostics and suggest new ways of treatment. Therefore, the epiXchange conference centers following main themes:
GENETICS:
State of the art and beyond state of the art exploring and developing novel treatment strategies based on optogenetics, gene and stem cell therapies.
THERAPEUTICS:
Development of effective epileptogenic therapeutics face different kinds of bottlenecks e.g. regulatory hurdles.
BIOMARKERS:
In order to develop novel preventive strategies in at-risk patients the identification of new biomarkers in blood, peripheral organs, braun tissue, electrophysical data, behavioural data and imaging data.
BIOBANKS AND DATABASES:
Biobanks and databases facilitate preclinical research and could be integrated into clinical care. A collaborative approach will lay a foundation for the future of epilepsy research and other disease model biobanks.
CO-MORBIDITIES:
The burden of co-morbidities in epilepsy is high. Mechanisms underlying bidirectional relations between epilepsy and neurological co-morbidities still need to be explored.
REGISTRATION:
The deadline for registration is 24 April 2018. To register, please click here: http://www.epixchange2018.eu/registration
epiXchange is a dissemination activity of the FP7 funded projects DESIRE, EpimiRNA, EpiTarget and EPISTOP. DESIRE, EpimiRNA, EpiTarget and EPISTOP are Collaboration Projects funded by the European Union's 7th Framework Programme under respectively grant agreement n° 602531, n° 602130, n° 602102, n° 602391.
Keywords
epilepsy, EpilepsyAwareness, EndEpilepsy, epiXchange2018, Collaboration